According to this panel we found that the vast majority of MDSC expanded in BC patients are HLA-DR-CD33+CD11b+ CD14-CD15- therefore not expressing the differentiation markers (Figure 1A and Supplementary Figure 1B for gating strategy). The gene discussed is CD14; the disease is breast cancer.